Results 91 to 100 of about 47,532 (242)

Weight‐reducing treatments are associated with an improvement in depression, functional health status, and quality of life: A meta‐analysis of randomized controlled trials

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aim To assess whether there is a beneficial or detrimental effect of weight reduction on mental health. Materials and methods Meta‐analysis of randomized trials performed for weight loss, in which weight loss at endpoint was greater than 5% in the intervention arm and smaller than 5% in the control arm, obtained with any surgical, endoscopic ...
Giovanni Antonio Silverii   +9 more
wiley   +1 more source

Efficacy and safety of European Medicines Agency (EMA)‐approved pharmacological, endoscopic, and surgical treatments in different classes of obesity: A network meta‐analysis of randomised controlled trials for the development of the SIO (Società Italiana Obesità) Italian guidelines for the diagnosis and treatment of overweight and obesity

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims We aimed at comparing different approved strategies (obesity management medications—OMM, endoscopic bariatric procedures—EBP, and metabolic bariatric surgery—MBS) with lifestyle intervention/placebo/no therapy (LSI/Pbo/NT) for the treatment of different BMI‐based classes of obesity (i.e., overweight—BMI: 25–29.9 kg/m2; class I—BMI: 30–34 ...
Rocco Barazzoni   +10 more
wiley   +1 more source

Methylphenidate, Bupropion, and SSRI Triple Therapy [PDF]

open access: yes, 2012
Methylphenidate and bupropion have been demonstrated as being effective adjuncts to serotonin reuptake inhibitors in the treatment of depression (1,2). The use of these medications in case of a depressed patient whose condition was resistant to several ...
Bobo, William, M.D.
core   +1 more source

Improved health‐related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT‐5 trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims In SURMOUNT‐5, tirzepatide led to greater body weight (BW) reduction versus semaglutide in adults with obesity without T2D. Health‐related quality of life (HRQoL) with tirzepatide versus semaglutide in SURMOUNT‐5 was evaluated. Materials and Methods This analysis included on‐treatment data from participants who received ≥1 dose of ...
Alpana P. Shukla   +5 more
wiley   +1 more source

Food and the brain: Neural and endocrine control of feeding, metabolism, and reproduction

open access: yesJournal of Neuroendocrinology, EarlyView.
Abstract Feeding and reproductive function are regulated by intricate systems that monitor food availability and energy stores, and on the basis of energy status, promote or put a brake on reproduction. This is particularly evident in the systems that regulate feeding and reproductive state in female mammals.
Naira da Silva Mansano   +2 more
wiley   +1 more source

The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence [PDF]

open access: yes
BACKGROUND: Tobacco smoking is the cause of many preventable diseases and premature deaths in the UK and around the world. It poses enormous health- and non-health-related costs to the affected individuals, employers, and the society at large.
Brown, AK, Ekpu, VU
core   +1 more source

The Novel CYP2A6 Inhibitor, DLCI-1, Decreases Nicotine Self-Administration in Mice. [PDF]

open access: yes, 2020
During tobacco and e-cigarette use, nicotine is mainly metabolized in the human liver by cytochrome P450 2A6 (CYP2A6). Given that a slower CYP2A6 metabolism has been associated with less vulnerability to develop nicotine dependence, the current studies ...
Chen, Yen-Chu   +8 more
core  

Comparing the Effects of Bupropion and Escitalopram on Excessive Internet Game Play in Patients with Major Depressive Disorder

open access: yesClinical Psychopharmacology and Neuroscience, 2017
Objective Several studies have suggested the efficacy of bupropion and escitalopram on reducing the excessive internet game play. We hypothesized that both bupropion and escitalopram would be effective on reducing the severity of depressive symptoms and ...
Beomwoo Nam   +4 more
semanticscholar   +1 more source

Narcolepsy and rapid eye movement sleep

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Since the first description of narcolepsy at the end of the 19th Century, great progress has been made. The disease is nowadays distinguished as narcolepsy type 1 and type 2. In the 1960s, the discovery of rapid eye movement sleep at sleep onset led to improved understanding of core sleep‐related disease symptoms of the disease (excessive ...
Francesco Biscarini   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy